Inhibitory Activity of a Heterochromatin-associated Serpin (MENT) against Papain-like Cysteine Proteinases Affects Chromatin Structure and Blocks Cell Proliferation*

MENT (Myeloid andErythroid Nuclear Termination stage-specific protein) is a developmentally regulated chromosomal serpin that condenses chromatin in terminally differentiated avian blood cells. We show that MENT is an effective inhibitor of the papain-like cysteine proteinases cathepsins L and V. In addition, ectopic expression of MENT in mammalian cells is apparently sufficient to inhibit a nuclear papain-like cysteine proteinase and prevent degradation of the retinoblastoma protein, a major regulator of cell proliferation. MENT also accumulates in the nucleus, causes a strong block in proliferation, and promotes condensation of chromatin. Variants of MENT with mutations or deletions within the M-loop, which contains a nuclear localization signal and an AT-hook motif, reveal that this region mediates nuclear transport and morphological changes associated with chromatin condensation. Non-inhibitory mutants of MENT were constructed to determine whether its inhibitory activity has a role in blocking proliferation. These mutations changed the mode of association with chromatin and relieved the block in proliferation, without preventing transport to the nucleus. We conclude that the repressive effect of MENT on chromatin is mediated by its direct interaction with a nuclear protein that has a papain-like cysteine proteinase active site.

[1]  J. Whisstock,et al.  Cleaved antitrypsin polymers at atomic resolution , 2008, Protein science : a publication of the Protein Society.

[2]  A. Harel-Bellan,et al.  The Rb/chromatin connection and epigenetic control: opinion , 2001, Oncogene.

[3]  D. Lomas,et al.  Polymerization of Plasminogen Activator Inhibitor-1* , 2001, The Journal of Biological Chemistry.

[4]  R. Read,et al.  Structure of a serpin–protease complex shows inhibition by deformation , 2000, Nature.

[5]  C. S. Pillay,et al.  Use of 2-methylpropan-2-ol to inhibit proteolysis and other protein interactions in a tissue homogenate: an illustrative application to the extraction of cathepsins B and L from liver tissue. , 2000, Analytical biochemistry.

[6]  D. Lomas.  Loop-sheet polymerization: the mechanism of alpha1-antitrypsin deficiency. , 2000, Respiratory medicine.

[7]  J. Whisstock,et al.  Simple modifications of the serpin reactive site loop convert SCCA2 into a cysteine proteinase inhibitor: a critical role for the P3' proline in facilitating RSL cleavage. , 2000, Biochemistry.

[8]  J. Harbour,et al.  Rb function in cell-cycle regulation and apoptosis , 2000, Nature Cell Biology.

[9]  R. Read,et al.  A 2.6 A structure of a serpin polymer and implications for conformational disease. , 1999, Journal of molecular biology.

[10]  J. Bednar,et al.  MENT, a Heterochromatin Protein That Mediates Higher Order Chromatin Folding, Is a New Serpin Family Member* , 1999, The Journal of Biological Chemistry.

[11]  E. Mehler,et al.  Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization. , 1999, Biochemistry.

[12]  T. Nagaya,et al.  Cleavage of RXRalpha by a lysosomal enzyme, cathepsin L-type protease. , 1999, Biochemical and biophysical research communications.

[13]  T. Nagaya,et al.  Intracellular Proteolytic Cleavage of 9-cis-Retinoic Acid Receptor α by Cathepsin L-type Protease Is a Potential Mechanism for Modulating Thyroid Hormone Action* , 1998, The Journal of Biological Chemistry.

[14]  D. Brömme,et al.  The reactive site loop of the serpin SCCA1 is essential for cysteine proteinase inhibition. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  U. Hellman,et al.  Inactivation of papain by antithrombin due to autolytic digestion: a model of serpin inactivation of cysteine proteinases. , 1998, The Biochemical journal.

[16]  D. Landsman,et al.  AT-hook motifs identified in a wide variety of DNA-binding proteins. , 1998, Nucleic acids research.

[17]  D. Musil,et al.  Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide. , 1998, Structure.

[18]  H. Chapman,et al.  Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis. , 1998, Biochemistry.

[19]  J. Whisstock,et al.  An atlas of serpin conformations. , 1998, Trends in biochemical sciences.

[20]  S. Grigoryev,et al.  Chromatin Structure in Granulocytes , 1998, The Journal of Biological Chemistry.

[21]  T. Nishinaka,et al.  A retinoblastoma susceptibility gene product, RB, targeting protease is regulated through the cell cycle , 1998, FEBS letters.

[22]  K. Yokoyama,et al.  A unique cathepsin-like protease isolated from CV-1 cells is involved in rapid degradation of retinoblastoma susceptibility gene product, RB, and transcription factor SP1. , 1997, Biochimica et biophysica acta.

[23]  M. Mcgrath,et al.  Expression of human cathepsin K in Pichia pastoris and preliminary crystallographic studies of an inhibitor complex , 1997, Protein science : a publication of the Protein Society.

[24]  H. Wright.  The structural puzzle of how serpin serine proteinase inhibitors work , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[25]  A. Rizzino,et al.  Appearance of nuclear protease activity after embryonal carcinoma cells undergo differentiation. , 1996, Developmental biology.

[26]  D. Brömme,et al.  Human Cathepsin O2, a Matrix Protein-degrading Cysteine Protease Expressed in Osteoclasts , 1996, The Journal of Biological Chemistry.

[27]  R. Pike,et al.  Mature cathepsin L is substantially active in the ionic milieu of the extracellular medium. , 1995, Archives of biochemistry and biophysics.

[28]  R. Pike,et al.  Baboon (Papio ursinus) cathepsin L: purification, characterization and comparison with human and sheep cathepsin L. , 1995, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[29]  C. Pace,et al.  How to measure and predict the molar absorption coefficient of a protein , 1995, Protein science : a publication of the Protein Society.

[30]  T. Komiyama,et al.  Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition. , 1994, The Journal of biological chemistry.

[31]  J. Huntington,et al.  Alpha 1-proteinase inhibitor variant T345R. Influence of P14 residue on substrate and inhibitory pathways. , 1994, Biochemistry.

[32]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[33]  R. Carrell,et al.  Effects of mutations in the hinge region of serpins. , 1993, Biochemistry.

[34]  S. Grigoryev,et al.  Stage-specific expression and localization of MENT, a nuclear protein associated with chromatin condensation in terminally differentiating avian erythroid cells. , 1993, Experimental cell research.

[35]  N. Barrass,et al.  Phenobarbital-induced hepatocellular proliferation: anti-bromodeoxyuridine and anti-proliferating cell nuclear antigen immunocytochemistry. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[36]  R. Black,et al.  Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme , 1992, Cell.

[37]  G. Rovelli,et al.  Characterization of the heparin-binding site of glia-derived nexin/protease nexin-1. , 1992, Biochemistry.

[38]  A G Leslie,et al.  Crystal structure of uncleaved ovalbumin at 1.95 A resolution. , 1991, Journal of molecular biology.

[39]  A. Roche,et al.  Organic Chemistry: , 1982, Nature.

[40]  A. Gropp,et al.  Staining of constitutive heterochromatin in mammalian chromosomes with a new fluorochrome. , 1972, Experimental cell research.

[41]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[42]  A. Berger,et al.  On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.

[43]  C. P. Huber,et al.  Structural basis of inhibition of cysteine proteases by E-64 and its derivatives. , 1999, Biopolymers.

[44]  M. Mcgrath.  The lysosomal cysteine proteases. , 1999, Annual review of biophysics and biomolecular structure.

[45]  N. Katunuma,et al.  Electrophoretic analysis of the “cross‐class” interaction between novel inhibitory serpin, squamous cell carcinoma antigen‐1 and cysteine proteinases , 1997, Electrophoresis.

[46]  R. Pike,et al.  Localization of an immunoinhibitory epitope of the cysteine proteinase, cathepsin L. , 1992, Immunological investigations.

[47]  A. Barrett,et al.  L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. , 1982, The Biochemical journal.